Literature DB >> 2425352

Identification of effector residues and a neutralizing epitope of Ha-ras-encoded p21.

I S Sigal, J B Gibbs, J S D'Alonzo, E M Scolnick.   

Abstract

To identify the amino acid residues of the Harvey (Ha) ras-encoded protein that are involved in protein-protein interactions, we have created a series of mutant Ha-ras proteins. In particular, amino acid substitutions have been introduced within two regions, residues 32-42 and 61-80, that are conserved among ras proteins from different species. We observed that amino acid substitutions at positions 35, 36, 38, 40, and, to a lesser extent, 39 and 78 reduce the biological potency of Ha-ras protein in both mammalian and Saccharomyces cerevisiae cells, without noticeably affecting the known intrinsic biochemistry of these proteins. The reduction of in vivo activity for these mutant ras proteins correlates with their reduced ability to stimulate yeast adenylate cyclase. The ras-protein-neutralizing antibody Y13-259 binds to six residues: Glu-63, Ser-65, Ala-66, Met-67, Gln-70, and Arg-73. Single substitutions for these residues reduce Y13-259 antibody binding by at least a factor of 1000 but do not significantly affect biological activity. These data are discussed in terms of the model for Ha-ras protein based on the structure of the elongation factor EF-Tu-GDP complex.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425352      PMCID: PMC323814          DOI: 10.1073/pnas.83.13.4725

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Use of helical wheels to represent the structures of proteins and to identify segments with helical potential.

Authors:  M Schiffer; A B Edmundson
Journal:  Biophys J       Date:  1967-03       Impact factor: 4.033

2.  Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins.

Authors:  D Broek; N Samiy; O Fasano; A Fujiyama; F Tamanoi; J Northup; M Wigler
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

Review 3.  Three-dimensional structure of immunoglobulins.

Authors:  D R Davies; E A Padlan; D M Segal
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

4.  A model for the tertiary structure of p21, the product of the ras oncogene.

Authors:  F McCormick; B F Clark; T F la Cour; M Kjeldgaard; L Norskov-Lauritsen; J Nyborg
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

5.  Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins.

Authors:  F Jurnak
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

6.  On ras gene function in yeast.

Authors:  D G Fraenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.

Authors:  I S Sigal; J B Gibbs; J S D'Alonzo; G L Temeles; B S Wolanski; S H Socher; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Structural details of the binding of guanosine diphosphate to elongation factor Tu from E. coli as studied by X-ray crystallography.

Authors:  T F la Cour; J Nyborg; S Thirup; B F Clark
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

10.  Molecular cloning and sequence analysis of a ras gene from Schizosaccharomyces pombe.

Authors:  Y Fukui; Y Kaziro
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  79 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

2.  Design of protein struts for self-assembling nanoconstructs.

Authors:  Paul Hyman; Regina Valluzzi; Edward Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

3.  GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites.

Authors:  A Valencia; M Kjeldgaard; E F Pai; C Sander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line.

Authors:  G T Drivas; A Shih; E Coutavas; M G Rush; P D'Eustachio
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

5.  Two forms of Drosophila melanogaster Gs alpha are produced by alternate splicing involving an unusual splice site.

Authors:  F Quan; M A Forte
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Complete nucleotide sequences of seven eubacterial genes coding for the elongation factor Tu: functional, structural and phylogenetic evaluations.

Authors:  W Ludwig; M Weizenegger; D Betzl; E Leidel; T Lenz; A Ludvigsen; D Möllenhoff; P Wenzig; K H Schleifer
Journal:  Arch Microbiol       Date:  1990       Impact factor: 2.552

7.  Distribution of polypeptides binding guanosine 5'-[gamma-[35S]thio]triphosphate and anti-(ras protein) antibodies in liver subcellular fractions. Evidence for endosome-specific components.

Authors:  N Ali; W H Evans
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

8.  Functions and functional domains of the GTPase Cdc42p.

Authors:  K G Kozminski; A J Chen; A A Rodal; D G Drubin
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

9.  Differential activation of yeast adenylyl cyclase by Ras1 and Ras2 depends on the conserved N terminus.

Authors:  N Hurwitz; M Segal; I Marbach; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.